MOLECULAR-BASIS FOR THE SPECIES SELECTIVITY OF THE NEUROKININ-1 RECEPTOR ANTAGONIST-CP-96,345 AND ANTAGONIST-RP67580

被引:0
|
作者
FONG, TM
YU, H
STRADER, CD
机构
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two non-peptide substance P antagonists exhibit opposite rank orders of potency for the human and rat neurokinin-I receptors. CP-96,345 shows selectivity for the human receptor, whereas RP67580 shows selectivity for the rat receptor. Amino acid sequence comparison of the two receptors reveals 22 divergent residues. To elucidate the molecular basis for the species selectivity of these antagonists, divergent residues in the human neurokinin-1 receptor were substituted by the rat homologs. Analysis of mutant receptors revealed that substitution of 2 residues (V116L and I290S) in the transmembrane domain of the human neurokinin-1 receptor is both necessary and sufficient to reproduce the antagonist binding affinities of the rat receptor. The nature of these substitutions and the magnitude of the changes in binding affinity suggest that residues 116 and 290 do not interact directly with the antagonist molecules. The present results support a model in which phylogenetically conserved residues interact directly with the antagonists, while phylogenetically divergent residues affect the local helical packing of the receptor. Such a change in local structure would lead to increased binding affinity for one class of antagonists and decreased affinity for another.
引用
收藏
页码:25668 / 25671
页数:4
相关论文
共 50 条
  • [1] MOLECULAR-BASIS FOR THE SPECIES SELECTIVITY OF THE SUBSTANCE-P ANTAGONIST-CP-96,345
    SACHAIS, BS
    SNIDER, RM
    LOWE, JA
    KRAUSE, JE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (04) : 2319 - 2323
  • [2] The neurokinin-1 receptor antagonist RP 67580 reduces the sensitization of primary afferents by substance P in the rat
    Pawlak, M
    Schmidt, RF
    Heppelmann, B
    Hanesch, U
    [J]. EUROPEAN JOURNAL OF PAIN, 2001, 5 (01) : 69 - 79
  • [3] Photoaffinity labeling of the human substance P (Neurokinin-1) receptor with [H-3(2)]azido-CP-96,345, a photoreactive derivative of a nonpeptide antagonist
    Macdonald, D
    Silberman, SC
    Lowe, JA
    Drozda, SE
    Leeman, SE
    Boyd, ND
    [J]. MOLECULAR PHARMACOLOGY, 1996, 49 (05) : 808 - 813
  • [4] SPECIFIC RESIDUES AT THE TOP OF TRANSMEMBRANE SEGMENT-V AND SEGMENT-VI OF THE NEUROKININ-1 RECEPTOR INVOLVED IN BINDING OF THE NONPEPTIDE ANTAGONIST CP-96,345
    GETHER, U
    NILSSON, L
    LOWE, JA
    SCHWARTZ, TW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 23959 - 23964
  • [5] Design and synthesis of hydrazo and azo analogues of CP-96,345 as neurokinin-1 receptor antagonists.
    Bangera, M
    Korlipara, VL
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 223 - MEDI
  • [6] Neurokinin-1 Receptor Antagonist Treatment in Polymicrobial Sepsis: Molecular Insights
    Hegde, Akhil
    Koh, Yung-Hua
    Moochhala, Shabbir M.
    Bhatia, Madhav
    [J]. INTERNATIONAL JOURNAL OF INFLAMMATION, 2010, 2010
  • [7] NONPEPTIDE ANTAGONISTS, CP-96,345 AND RP-67580, DISTINGUISH SPECIES VARIANTS IN TACHYKININ NK(1)-RECEPTORS
    BARR, AJ
    WATSON, SP
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) : 223 - 227
  • [8] PHARMACOLOGY OF CP-99,994 - A NONPEPTIDE ANTAGONIST OF THE TACHYKININ NEUROKININ-1 RECEPTOR
    MCLEAN, S
    GANONG, A
    SEYMOUR, PA
    SNIDER, RM
    DESAI, MC
    ROSEN, T
    BRYCE, DK
    LONGO, KP
    REYNOLDS, LS
    ROBINSON, G
    SCHMIDT, AW
    SIOK, C
    HEYM, J
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (01): : 472 - 479
  • [9] THE EFFECT OF INTRATHECAL ADMINISTRATION OF RP67580, A POTENT NEUROKININ-1 ANTAGONIST ON NOCICEPTIVE TRANSMISSION IN THE RAT SPINAL-CORD
    CHAPMAN, V
    DICKENSON, AH
    [J]. NEUROSCIENCE LETTERS, 1993, 157 (02) : 149 - 152
  • [10] EFFECT OF RP 67580, A NONPEPTIDE NEUROKININ(1) RECEPTOR ANTAGONIST, ON FACILITATION OF A NOCICEPTIVE SPINAL FLEXION REFLEX IN THE RAT
    LAIRD, JMA
    HARGREAVES, RJ
    HILL, RG
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 (03) : 713 - 718